Shire PLC

Pharmaceuticals
Ireland
2016 Revenue (US$ Millions)$11,397
Revenue Growth (%)77.61%
Net Income (US$ Millions)$327
Earnings Per Share (US$)$0.42
EPS Growth Rate (%)-80.88%
Profit Margin2.87%
Total Equity (US$ Millions)$28,948
Return on Equity (%)3.33%
Long Term Debt (US$ Millions)$19,900
Debt To Equity Ratio (%)0.69%
Total Assets (US$ Millions)$67,035
Current Assets (US$ Millions)$7,540
Current Liabilities (US$ Millions)$7,743
Cost of Goods Sold (US$ Millions)$3,817
Inventory Turnover1.82